BioMedical Strategy’s Regulatory & Clinical affairs experts offer their clients close assistance in developing a comprehensive and tailor-made strategy to bring their innovative products to markets globally. By closely communicating with both the companies and the regulatory authorities, we develop the ‘least burdensome’ pathway and its efficient implementation through the pre-clinical and clinical phases.
- FROM STRATEGY TO MARKET
- Regulatory Strategy
- Pre clinical [bench and in vivo] plan
- Clinical planning and design